SCHEMBL42325

SCHEMBL42325

O=C(O)C=Cc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.71
KMT2A Q03164 3/20 0.71
MAOB P27338 6/20 0.68
BCHE P06276 1/20 0.68
CYP1B1 Q16678 1/20 0.63
APP P05067 1/20 0.60
MAOA P21397 4/20 0.59
FBP1 P09467 1/20 0.58
RHOA P61586 1/20 0.57
HCAR2 Q8TDS4 2/20 0.57
CA12 O43570 1/20 0.57
AKR1B10 O60218 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
ESR1 P03372 1/20 0.57
CA3 P07451 1/20 0.57
PKM P14618 1/20 0.57
TYR P14679 1/20 0.57
AKR1B1 P15121 1/20 0.57
CA4 P22748 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL277169 1.00 MEN1 (0.71) MEN1KMT2AMAOBBCHECYP1B1
Benzene SCHEMBL6915910 0.98 MAOB (0.71) MEN1KMT2AMAOBBCHECYP1B1
SCHEMBL29077145 0.98 MEN1 (0.69) MEN1KMT2AMAOBBCHECYP1B1
SCHEMBL27867390 0.98 MEN1 (0.69) MEN1KMT2AMAOBBCHECYP1B1
SCHEMBL27883557 0.98 MEN1 (0.69) MEN1KMT2AMAOBBCHECYP1B1
Hydrochloric Acid SCHEMBL4989762 0.98 MEN1 (0.69) MEN1KMT2AMAOBBCHECYP1B1
SCHEMBL11836065 0.95 MEN1 (0.65) MEN1KMT2AMAOBBCHECYP1B1
SCHEMBL11836067 0.95 MEN1 (0.65) MEN1KMT2AMAOBBCHECYP1B1
SCHEMBL17457069 0.92 MAOB (0.63) MEN1KMT2AMAOBBCHECYP1B1
Alcohol SCHEMBL8131569 0.92 MEN1 (0.66) MEN1KMT2AMAOBBCHECYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1615 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070479-A Ultrasonic indicating device and method for monitoring ultrasonic treatment JP实验室股份有限公司 2026-05-19 CN claimed
EP-4673529-A1 USE OF GELATIN IN A SUPPORT MATERIAL FOR EMBEDDED PRINTING Rousselot BV (BE) 2026-01-07 EP claimed
US-12497636-B2 Recombinant Saccharomyces cerevisiae cells for cannabinoid production NATIONAL UNIVERSITY OF SINGAPORE (SG) 2025-12-16 US claimed
US-20250320333-A1 COMPOSITION FOR PREPARING POLYCAPROLACTONE SHAPE MEMORY MATERIAL, AND POLYCAPROLACTONE SHAPE MEMORY MATERIAL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF CHINA PETROLEUM & CHEM CORP (CN) 2025-10-16 US claimed
US-20250271441-A1 APPLICATION OF CLICK CHEMISTRY FOR SIGNAL AMPLIFICATION IN IHC AND ISH ASSAYS VENTANA MED SYST INC (US) 2025-08-28 US claimed
US-12398419-B2 Automated RNA detection using labeled 2′-O-methyl RNA oligonucleotide probes and signal amplification systems VENTANA MEDICAL SYSTEMS, INC. (US) 2025-08-26 US claimed
US-12365830-B2 Ligand-exchangeable janus nanoparticles and methods of making the same ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) 2025-07-22 US claimed
CN-120082047-A Porous coordination polymer and preparation method and application thereof 中国石油化工股份有限公司 2025-06-03 CN claimed
WO-2025090061-A1 ULTRASONIC INDICATOR DEVICE AND METHOD FOR MONITORING ULTRASONICATION JP LABORATORIES, INC. (US) 2025-05-01 WO claimed
WO-2025075611-A1 ULTRASONIC INDICATOR BASED ON EMULSION FORMATION JP LABORATORIES, INC. (US) 2025-04-10 WO claimed
US-5035976-A Photoresists, improved shelf life HOECHST CELANESE CORPORATION (US) 1991-07-30 US claimed
EP-0166542-B1 TRITERPENYL ESTERS OF ORGANIC ACIDS, PROCESS FOR THEIR PRODUCTION, AND HYPOLIPIDEMIC AGENTS COMPOSED OF THEM AMANO PHARMACEUTICAL CO., LTD. (JP) 1990-08-08 EP claimed
EP-0155123-B1 YELLOW COLOR FORMERS FOR USE IN COLOR PHOTOTHERMOGRAPHIC SYSTEM MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1990-04-11 EP claimed
US-4748161-A Triterpenyl esters of organic acids and hypolipidemic agents composed of them AMANO PHARMACEUTICAL CO., LTD. (JP) 1988-05-31 US claimed
EP-0166542-A2 Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them AMANO PHARMACEUTICAL CO., LTD. (JP) 1986-01-02 EP claimed
EP-0155123-A2 Yellow color formers for use in color photothermographic system MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1985-09-18 EP claimed
US-4535056-A OXIDIZER, BIPHENOL REDUCING AGENT, AND CARBOXYLIC ACID MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1985-08-13 US claimed
US-4223948-A Process for the reduction of competitive oxidant consuming reactions in the solution mining of a mineral ATLANTIC RICHFIELD COMPANY (US) 1980-09-23 US claimed
US-4009033-A 1,2-QUINONE DIAZIDE SULFONATE AND NICOTINIC, PICRIC OR NITROCINNAMIC ACID INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1977-02-22 US claimed
US-3981775-A GRAFTING NITRO MONOMER ON TO POLYMER, AMINATION, DIAZOTIZATION, ISOTHIOCYANATO FORMATION KENYON ROBERT SYDNEY 1976-09-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250271441-A1 APPLICATION OF CLICK CHEMISTRY FOR SIGNAL AMPLIFICATION IN IHC AND ISH ASSAYS MKI67, TIE1, ALK MEN1 2491/4885KMT2A 183/4885MAOB 1677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.